Truvada case shows civil society’s success with pre-grant opposition

Gilead has met resistance from civil society groups in some countries when trying to patent the combination drug, and in particular in Argentina and Brazil, where civil society has filed patent oppositions. In Argentina, Gilead withdrew its patent application, while in Brazil, according to sources, the global pharmaceutical company might push its case to courts.

Read More

AIDS runs rampant in Venezuela and puts an ancient culture at risk

According to New York Times, the shortage of medicines generated by the crisis and the cutback in public health policies resulted in a jump in the number of indigenous people killed due to AIDS, a disease caused by the HIV virus. After the other villagers had drifted away to do chores, Rafael Pequeño finally found himself alone with the headman and opened the hardcover notebook on his lap. The men were sitting in a palm-thatched hut perched on stilts on the edge of a branch of the Orinoco River.

Read More

Gilead’s patent application on sofosbuvir rejected in Brazil

The Working Group on Intellectual Property of the Brazilian Network for Integration of Peoples (GTPI/Rebrip), a coalition of civil society organizations and activists coordinated by the Brazilian Interdisciplinary Aids Association (ABIA), filed several patent oppositions in this case.

Read More

Patent on Hep C drug rejected in Ukraine: price of sofosbuvir will significantly reduce

The Ministry of Economic Development and Trade of Ukraine (MEDT) refused to grant the pharmaceutical company Gilead a patent for hepatitis C drug sofosbuvir. On 2 March 2018, the MEDT issued the order (No. 305) which approved the decision to reject the patent application. If issued, a patent could give the company a 20-year monopoly on the import of sofosbuvir to Ukraine.

Read More


Publications


Infographic

AIDS in the world

AIDS in the world

See the trajectory
of the AIDS epidemic.

Newsletter

Newsletter

Your Name (required):


Your Email (required)

Please fill all widget settings!

Facebook